Recurrence

"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The return of a sign, symptom, or disease after a remission.

Descriptor ID	D012008
MeSH Number(s)	C23.550.291.937
Concept/Terms	Recurrence Recurrence Recurrences Recrudescence Recrudescence Recrudescences Relapse Relapse Relapses

Below are MeSH descriptors whose meaning is more general than "Recurrence".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Disease Attributes [C23.550.291]
Recurrence [C23.550.291.937]

Below are MeSH descriptors whose meaning is related to "Recurrence".

Below are MeSH descriptors whose meaning is more specific than "Recurrence".

Recurrence
Symptom Flare Up

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.

Bar chart showing 128 publications over 28 distinct years, with a maximum of 13 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	2	2
1998	0	1	1
1999	0	1	1
2001	0	1	1
2002	0	4	4
2003	0	6	6
2004	0	2	2
2005	0	7	7
2006	0	6	6
2007	1	6	7
2008	0	4	4
2009	0	5	5
2010	0	3	3
2011	0	10	10
2012	0	7	7
2013	0	5	5
2014	0	8	8
2015	0	5	5
2016	0	4	4
2017	0	13	13
2018	0	3	3
2019	0	3	3
2020	1	3	4
2021	0	4	4
2022	0	2	2
2023	0	3	3
2024	3	1	4
2025	0	4	4

Below are the most recent publications written about "Recurrence" by people in Profiles.

Jones AA, Robison JH, Smit T, Brett E, Zvolensky MJ, Garey L. Nicotine dependence, perceived barriers, and affective vulnerability among individuals engaging in dual use who report relapse: Implications for targeted treatment. Addict Behav. 2025 Nov; 170:108422.

View in: PubMed
Huang Z, Cheng XQ, Lu RR, Liu YN, Bi XJ, Deng YB. Correlation of plaque vulnerability stratified by Carotid Plaque-Reporting and Data System with outcomes of endarterectomy vs stenting. J Vasc Surg. 2025 Oct; 82(4):1299-1310.e2.

View in: PubMed
Bakhshaie J, Ditre JW, Clausen BK, Redmond BY, Ly T, Zvolensky MJ. Pain Interference and Intensity in Relation to Abstinence Outcomes Following a One-Session Personalized Feedback Smoking Cessation Digital-Intervention. Subst Use Misuse. 2025; 60(5):742-748.

View in: PubMed
Liu Y, Bollino DR, Bah OM, Strovel ET, Le TV, Zarrabi J, Philip S, Lapidus RG, Baer MR, Niyongere S, Duong VH, Dougherty CC, Beumer JH, Caprinolo KD, Kamangar F, Emadi A. A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia. Blood. 2025 01 30; 145(5):486-496.

View in: PubMed
Huang Z, Cheng XQ, Lu RR, Bi XJ, Liu YN, Deng YB. Incremental Prognostic Value of Carotid?Plaque-RADS Over Stenosis Degree in Relation to Stroke Risk. JACC Cardiovasc Imaging. 2025 Jan; 18(1):77-89.

View in: PubMed
Morales-Silva RJ, Perez-Perez Y, Alvarado-Torres J, Rivera-Aviles N, Rodriguez-Torres G, Gelpi-Dominguez U, Dominguez-Padovani B, Amador-Maldonado A, Sepulveda-Orengo MT. Sex-specific effects of chronic stress prior to cocaine exposure on cue- vs drug-induced relapse after prolonged abstinence. Behav Brain Res. 2024 10 02; 474:115197.

View in: PubMed
de Havenon A, Viscoli C, Kleindorfer D, Sucharew H, Delic A, Becker C, Robinson D, Yaghi S, Li V, Lansberg MG, Cramer SC, Mistry EA, Sarpong DF, Kasner SE, Kernan W, Sheth KN. Disability and Recurrent Stroke Among Participants in Stroke Prevention Trials. JAMA Netw Open. 2024 07 01; 7(7):e2423677.

View in: PubMed
Nahm WJ, Juarez M, Abdul-Hay M, Bhatt A, Meehan SA, Shvartsbeyn M. Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. Am J Case Rep. 2024 May 18; 25:e943577.

View in: PubMed
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study. Inflamm Bowel Dis. 2023 11 02; 29(11):1730-1740.

View in: PubMed
Oesterheld J, Ferguson W, Kraveka JM, Bergendahl G, Clinch T, Lorenzi E, Berry D, Wada RK, Isakoff MS, Eslin DE, Brown VI, Roberts W, Zage P, Harrod VL, Mitchell DS, Hanson D, Saulnier Sholler GL. Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons. J Clin Oncol. 2024 Jan 01; 42(1):90-102.

View in: PubMed

People

Explore

Similar Concepts

Top Journals